Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsAntibodies, Monoclonal, Murine-DerivedPeripheral Blood Stem Cell TransplantationCombined Modality TherapyMultiple MyelomaMelphalanCyclophosphamideTreatment OutcomeTransplantation, HomologousTransplantation ConditioningVincristineDisease-Free SurvivalRemission InductionDoxorubicinSalvage TherapyEtoposideLymphoma, Non-HodgkinPrednisoneHodgkin DiseaseStem CellsLymphoma, FollicularLymphoma, Mantle-CellSurvival RateLymphoma, Large B-Cell, DiffuseRecurrenceCytarabineHematopoietic Stem Cell MobilizationSurvival AnalysisMyeloablative AgonistsCarmustineAntibodies, MonoclonalBone Marrow TransplantationGraft vs Host DiseaseThiotepaAntineoplastic AgentsBone Marrow PurgingPrognosisHematologic NeoplasmsRetrospective StudiesChemotherapy, AdjuvantWhole-Body IrradiationFollow-Up StudiesAmyloidosisDexamethasoneBoronic AcidsHematopoietic Stem CellsBusulfanPyrazinesAntineoplastic Agents, AlkylatingCisplatinGraft SurvivalGranulocyte Colony-Stimulating FactorIfosfamideInduction ChemotherapyNitrogen Mustard CompoundsAntigens, CD34Lymphoma, T-Cell, PeripheralTime FactorsAutograftsThalidomideLiver TransplantationLymphomaLeukapheresisLymphoma, B-CellMesenchymal Stem Cell TransplantationCarboplatinMaintenance ChemotherapyNeoplasm, ResidualPodophyllotoxinNeoplasm Recurrence, LocalLeukemia, Myeloid, AcuteTransplantation ChimeraNeoplasm StagingDrug Administration ScheduleProspective StudiesMitoxantroneAntigens, CD20Tissue DonorsCord Blood Stem Cell TransplantationBreast NeoplasmsCell TransplantationKidney TransplantationNeoplasms, Second PrimaryIdarubicinMyelodysplastic SyndromesBleomycinEnteropathy-Associated T-Cell LymphomaImmunosuppressive AgentsEmbryonic Stem CellsMethotrexateLeukemia, Plasma CellInfusions, SpinalKaplan-Meier EstimateNeutropeniaBlood Component RemovalFeasibility StudiesAdult Stem Cells